ADAR1 as a Placental Innate Immune Rheostat Sustaining the Homeostatic Balance of Intrinsic Interferon Response at the Maternal‐Fetal Interface
Source abstract
Abstract
Abstract The mechanisms that balance a robust intrinsic antiviral defense at the maternal‐fetal interface with fetal development remain elusive. Here, it is delineated that ADAR1, an adenosine‐to‐inosine (A‐to‐I) editor, fine‐tunes intrinsic interferon (IFN)‐mediated integrates stress response (ISR) in the mouse placenta, thereby orchestrating embryonic development and antiviral defense. Placental Adar1 deletion ( Adar1 PKO ) trigger spatially resolved overwhelming IFN responses, which impair the differentiation of IFN hyper‐responsive junctional zone (JZ) progenitors and functions of the placental JZ, ultimately causing embryonic death. Mechanistically, the Adar1 PKO placental IFN hyper‐response is positively amplified by the accumulated immunogenic dsRNAs from the 3′UTR of interferon‐stimulated genes (ISG‐3′UTR‐dsRNA). The resulting fetal death is rescued by concurrent deletion of Mavs , Ifnar1 , or Pkr , but not Zbp1 or cell death effectors. Notably, blocking ISR pharmacologically preventes embryonic lethality induced by Adar1 PKO JZ defects. These findings demonstrate that ADAR1 fine‐tunes the unique spatially resolved IFN‐PKR‐ISR signaling in the placenta by restricting ISG‐3′UTR‐dsRNA accumulation, highlighting a potential therapeutic strategy for treating interferonopathy‐associated pregnancy complications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA regulation and disease · RNA Research and Splicing · Viral Infections and Immunology Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Fujian Provincial Key Laboratory of Reproductive Health Research Cancer Research Center Department of Obstetrics and Gynecology Women and Children's Hospital School of Medicine Xiamen University Xiamen Fujian 361102 China
State Key Laboratory of Vaccines for Infectious Diseases Xiang An Biomedicine Laboratory School of Public Health Xiamen University Xiamen Fujian 361102 China
Funding
National Key Research and Development Program of China · China Postdoctoral Science Foundation · Fundamental Research Funds for the Central Universities
References (49)
Show source-provided references
1. 10.1126/sciimmunol.aat611410.1126/sciimmunol.aat6114 ↗
2. 10.1084/jem.2020064910.1084/jem.20200649 ↗
3. 10.1016/j.chom.2016.03.00810.1016/j.chom.2016.03.008 ↗
4. 10.1016/j.immuni.2018.07.01710.1016/j.immuni.2018.07.017 ↗
5. 10.15252/embr.20215245010.15252/embr.202152450 ↗
6. 10.1016/j.placenta.2011.11.00710.1016/j.placenta.2011.11.007 ↗
7. 10.1038/nrmicro.2016.12510.1038/nrmicro.2016.125 ↗
8. 10.1002/art.3902910.1002/art.39029 ↗
9. 10.1016/j.immuni.2024.03.00310.1016/j.immuni.2024.03.003 ↗
10. 10.1016/j.chom.2023.05.01810.1016/j.chom.2023.05.018 ↗
11. 10.1038/ng.36810.1038/ng.368 ↗
12. 10.1038/cr.2015.13510.1038/cr.2015.135 ↗
13. 10.1073/pnas.94.16.842110.1073/pnas.94.16.8421 ↗
14. 10.1038/s41431-019-0458-610.1038/s41431-019-0458-6 ↗
15. 10.1038/ng.241410.1038/ng.2414 ↗
16. 10.1016/j.celrep.2014.10.04110.1016/j.celrep.2014.10.041 ↗
17. 10.1126/science.aac704910.1126/science.aac7049 ↗
18. 10.1016/j.immuni.2015.11.00110.1016/j.immuni.2015.11.001 ↗
19. 10.1016/j.cell.2017.12.03810.1016/j.cell.2017.12.038 ↗
20. 10.1038/nature2600210.1038/nature26002 ↗
21. 10.3389/fendo.2018.0057010.3389/fendo.2018.00570 ↗
22. 10.1530/REP-21-039010.1530/REP-21-0390 ↗
23. 10.1038/s41586-022-04878-910.1038/s41586-022-04878-9 ↗
24. 10.1016/j.stem.2020.04.01610.1016/j.stem.2020.04.016 ↗
25. 10.1038/s41467-017-01458-810.1038/s41467-017-01458-8 ↗
26. 10.1038/s41577-023-00940-310.1038/s41577-023-00940-3 ↗
27. 10.1038/s41586-022-04753-710.1038/s41586-022-04753-7 ↗
28. 10.1002/dvg.2310110.1002/dvg.23101 ↗
29. 10.1146/annurev.biochem.76.060605.12284710.1146/annurev.biochem.76.060605.122847 ↗
30. 10.1016/j.immuni.2019.03.02510.1016/j.immuni.2019.03.025 ↗
31. 10.1074/jbc.M31016220010.1074/jbc.M310162200 ↗
32. 10.1016/j.immuni.2021.07.00110.1016/j.immuni.2021.07.001 ↗
33. 10.1016/j.molcel.2023.09.01810.1016/j.molcel.2023.09.018 ↗
34. 10.3389/fimmu.2021.70214210.3389/fimmu.2021.702142 ↗
35. Susan T. · Cell · 2005 · 122
36. 10.7554/eLife.6026610.7554/eLife.60266 ↗
37. 10.1002/dvdy.2098110.1002/dvdy.20981 ↗
38. 10.1261/rna.079953.12410.1261/rna.079953.124 ↗
39. 10.1038/s41586-022-04974-w10.1038/s41586-022-04974-w ↗
40. 10.1016/j.exphem.2016.06.25010.1016/j.exphem.2016.06.250 ↗
41. 10.1038/s41586-022-04896-710.1038/s41586-022-04896-7 ↗
42. 10.1016/j.cell.2013.02.05410.1016/j.cell.2013.02.054 ↗
43. 10.1126/science.aat531410.1126/science.aat5314 ↗
44. 10.1126/sciadv.adk103410.1126/sciadv.adk1034 ↗
45. 10.1086/37952410.1086/379524 ↗
46. 10.1038/s41423-019-0237-x10.1038/s41423-019-0237-x ↗
47. 10.1371/journal.pbio.300130410.1371/journal.pbio.3001304 ↗
48. 10.1186/1471-2164-9-35210.1186/1471-2164-9-352 ↗
49. 10.1038/nmeth.256310.1038/nmeth.2563 ↗